Cleared Traditional

Sterile Aesthetic Cannula and Hypodermic Needle (K223327) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K223327 · Shanghai Kindly Enterprise Development Group Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2023
Decision
108d
Days
Class 2
Risk

K223327 is an FDA 510(k) clearance for the Sterile Aesthetic Cannula and Hypodermic Needle. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Shanghai Kindly Enterprise Development Group Co., Ltd. (Shanghai, CN). The FDA issued a Cleared decision on February 16, 2023 after a review of 108 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Shanghai Kindly Enterprise Development Group Co., Ltd. devices

Submission Details

510(k) Number K223327 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 31, 2022
Decision Date February 16, 2023
Days to Decision 108 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 129d · This submission: 108d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Shanghai Mind-Link Consulting Co., Ltd.
Evan Hu

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 200
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K223327.
Nipro SafeTouch Needle
K222852 · Nipro Medical Corporation · May 2023
Disposable Insulin Pen Needle
K222739 · Hantech Medical Device Co., Ltd. · Apr 2023
Shina Safety Needle
K222417 · Shina Corporation · Mar 2023
Verisafe Safety sterile needles
K222271 · Promisemed Hangzhou Meditech Co., Ltd. · Feb 2023
Insupen Pen needle, Insupen ORIGINAL Pen Needle, Insupen ADVANCED pen needle
K203792 · Pikdare Spa · Jan 2023
BD AutoShield Duo™ Pen Needle
K223286 · Becton, Dickinson and Company · Dec 2022